Health equity and access to oocyte donation

Principles of Oocyte and Embryo Donation

Volumn 9781447123927, Issue , 2013, Pages 371-382

  Jones, Mavis ^a   Nisker, Jeff ^b,c  

^a ECHO: Improving Women's Health in Ontario   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84949180404     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4471-2392-7_27     Document Type: Chapter

References (126)

1. Gosden R, Rutherford A. Delayed childbearing. BMJ. 1995;311(7020):1585-6.
2. Hammarberg K, Clarke VE. Reasons for delaying childbearing -a survey of women aged over 35 years seeking assisted reproductive technology. Aust Fam Physician. 2005;34(3):187-8, 206.
3. Nisker J, Bergum V. A child on her mind: a play. In: Bergum V, Van Der Zalm J, editors. Mother life. Studies of mothering experience. Edmonton: Pedagon Publishing; 2007. p. 364-98.
4. Mykitiuk R, Nisker J. Social determinants of "health" of embryos. In: Nisker J, Baylis F, Karpin I, McLeod C, Mykitiuk R, editors. The "healthy" embryo: social, biomedical, legal and philosophical perspectives. Cambridge/New York: Cambridge University Press; 2010. p. 116-35.
5. Lucena E, Bernal DP, Lucena C, Rojas A, Moran A, Lucena A. Successful ongoing pregnancies after vitri fi cation of oocytes. Fertil Steril. 2006;85(1):108-11.
6. Cobo A, Diaz C. Clinical application of oocyte vitri fi cation: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2011;96(2): 277-85.
7. Garcia JI, Noriega-Portella L, Noriega-Hoces L. Ef fi cacy of oocyte vitri fi cation combined with blastocyst stage transfer in an egg donation program. Hum Reprod. 2011;26(4):782-90.
8. Nisker J. Distributive justice and infertility treatment in Canada. J Obstet Gynaecol Can. 2008;30(5):425-31.
9. Mykitiuk R, Nisker J. Assisted reproduction. In: Singer PA, Viens VA, editors. Bioethics for clinicians. Cambridge: Cambridge University Press; 2008.
10. Nisker JA. Rachel's Ladders or how societal situation determines reproductive therapy. Hum Reprod. 1996;11(6):1162-7.
11. Nisker JA. Anniversary of injustice: April fool's day, 1994. Will the enactment of bill C-6 be the birthday of equitable reproductive health care in Canada. J Obstet Gynaecol Can. 2004;26(4):321-4.
12. Purewal S, van den Akker OB. Systematic review of oocyte donation: investigating attitudes, motivations and experiences. Hum Reprod Update. 2009;15(5):499-515.
13. Kenney NJ, McGowan ML. Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their fi rst donation cycle. Fertil Steril. 2010;93(2):455-66.
14. Kim SS, Klemp J, Fabian C. Breast cancer and fertility preservation. Fertil Steril. 2011;95(5):1535-43.
15. Byrne J. Infertility and premature menopause in childhood cancer survivors. Med Pediatr Oncol. 1999;33(1): 24-8.
16. Nisker J, Baylis F, McLeod C. Choice in fertility preservation in girls and adolescent women with cancer. Cancer. 2006;107(7 Suppl):1686-9.
17. Kohler TS, Kondapalli LA, Shah A, Chan S, Woodruff TK, Brannigan RE. Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet. 2011;28(3):269-77.
18. Leader A, Lishner M, Michaeli J, Revel A. Fertility considerations and preservation in haemato-oncology patients undergoing treatment. Br J Haematol. 2011; 153(3):291-308.
19. Redig AJ, Brannigan R, Stryker SJ, Woodruff TK, Jeruss JS. Incorporating fertility preservation into the care of young oncology patients. Cancer. 2011;117(1): 4-10.
20. Pastor CL, Vanderhoof VH, Lim LC, et al. Pilot study investigating the age-related decline in ovarian function of regularly menstruating normal women. Fertil Steril. 2005;84(5):1462-9.
21. Anasti JN. Premature ovarian failure: an update. Fertil Steril. 1998;70(1):1-15.
22. Laml T, Preyer O, Umek W, Hengstschlager M, Hanzal H. Genetic disorders in premature ovarian failure. Hum Reprod Update. 2002;8(5):483-91.
23. Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update. 2005;11(4):391-410.
24. National Health and Medical Research Council. Ethical guidelines on the use of assisted reproductive technology in clinical practice and research. Australian Government 2007. http://www.nhmrc.gov.au/- fi les- nhmrc/publications/attachments/e78.pdf Accessed 11 Sept 2011.
25. Levine AD. The oversight and practice of oocyte donation in the United States, United Kingdom, and Canada. HEC Forum. 2011;23:15-30.
26. Adamson DG. Global cultural and socioeconomic factors that in fl uence access to assisted reproductive technologies. Womens Health. 2009;5(4):351-8.
27. Sperling D. Commanding the "be fruitful and multiply" directive: reproductive ethics, law, and policy in Israel. Camb Q Healthc Ethics. 2010;19(3):363-71.
28. Human fertilisation and embryology act. UK Department of Health 2008. http://www.legislation.gov.uk/ukpga/2008/22/ contents Accessed 11 Sept 2011.
29. Nisker JA. There is no gene for the human spirit. J Obstet Gynaecol Can. 2002;24(3):209-13.
30. Wolff J. Your Eggs: Buy Sell Freeze? Women's Health Magazine. Jan/Feb 2011. http://www.womenshealthmag. com/life/female-egg-donation Accessed 10 Dec 2012.
31. Nowoweiski S, Matic H, Foster P. Patient experiences in advertising for an egg donor. Reprod Biomed Online. 2011;22(7):686-91.
32. Ahuja KK, Simons EG, Edwards RG. Money, morals and medical risks: con fl icting notions underlying the recruitment of egg donors. Hum Reprod. 1999;14(2): 279-84.
33. Australia. Research involving human embryos act and prohibition of human cloning act 2003. Of fi ce of the Queensland Parliamentary Counsel 2003; Available at: URL: http://www.legislation.qld.gov.au/LEGISLTN/ CURRENT/R/ReseHumEmbA03.pdf Accessed 8 Sept 2011.
34. Marshall LA. Intergenerational gamete donation: ethical and societal implications. Am J Obstet Gynecol. 1998;178(6):1171-6.
35. Frith L. Gamete donation and anonymity: the ethical and legal debate. Hum Reprod. 2001;16(5):818-24.
36. Blyth E. Patient experiences of an "egg sharing" programme. Hum Fertil (Camb). 2004;7(3):157-62.
37. Kondro W. Debate over online recruitment of organ donors. CMAJ. 2005;172(2):165-6.
38. Delmonico FL, Arnold R, Scheper-Hughes N, Siminoff LA, Kahn J, Youngner SJ. Ethical incentives -not payment -for organ donation. N Engl J Med. 2002;346(25):2002-5.
39. Hanto DW. Ethical challenges posed by the solicitation of deceased and living organ donors. N Engl J Med. 2007;356(10):1062-6.
40. Belgium. Loi relative à la recherche sur les embryons in vitro. Federal Government 2011 November 5. http:// www.ejustice.just.fgov.be/cgi/summary-body.pllanguage=fr&pub-date=2003-05-28 Accessed 8 Sept 2011.
41. Israel. Public Health (In Vitro Fertilization) Regulations 5747-1987, KT No. 5035, p. 987.
42. Norway. Law No. 56 of 1994 (on the Medical Use of Biotechnology), Chap. 3. 2004.
43. The Netherlands. Embryos act. Rijksoverheid 2002. http://www.minvws.nl/images/eng-embryowettekst-tcm20-107819.pdf Accessed 8 Sept 2011.
44. Germany. Act for protection of embryos (The embryo protection act). 1990. http://www.auswaertiges-amt. de/cae/servlet/contentblob/480804/publication-File/5162/EmbryoProtectionAct.pdf .
45. Assisted Human Reproduction Act. Department of Justice Canada 2004. http://lois.justice.gc.ca/en/ ShowFullDoc/cs/A-13.4///en Accessed 15 Aug 2011.
46. France. Bioethics law no 94-654. 1994. http://www.legifrance.gouv.fr/affichTexte.docidTexte=JORFTE.XT000000549618&dateTexte=&categorieLien=id47
47. Sweden. In Vitro Fertilization Act SFS 1988:711.
48. Younis JS, Ezra Y, Laufer N, Ohel G. Late manifestation of pelvic abscess following oocyte retrieval, for in vitro fertilization, in patients with severe endometriosis and ovarian endometriomata. J Assist Reprod Genet. 1997;14(6):343-6.
49. Balen A. Ovarian hyperstimulation syndrome -a short report for the HFEA. HFEA 2005. http://www. hfea.gov.uk/docs/OHSS-Report-from-Adam- Balen-2005(1).pdf Accessed 31 Aug 2011.
50. Practice Committe of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2003;80(5):1309-14.
51. Miller PB, Price T, Nichols Jr. JE, Hill L. Acute ureteral obstruction following transvaginal oocyte retrieval for IVF. Hum Reprod. 2002;17(1):137-8.
52. Mertes H, Pennings G. Oocyte donation for stem cell research. Hum Reprod. 2007;22(3):629-34.
53. Abramov Y, Elchalal U, Schenker JG. Severe OHSS: an 'epidemic' of severe OHSS: a price we have to pay? Hum Reprod. 1999;14(9):2181-3.
54. George K. What about the women? ethical and policy aspects of egg supply for cloning research. Reprod Biomed Online. 2007;15(2):127-33.
55. Shatford LA, Brown SE, Yuzpe AA, Nisker JA, Casper RF. Assessment of experienced pain associated with transvaginal ultrasonography-guided oocyte recovery in in vitro fertilization patients. Am J Obstet Gynecol. 1989;160(4):1002-6.
56. Boivin J, Scanlan LC, Walker SM. Why are infertile patients not using psychosocial counselling? Hum Reprod. 1999;14(5):1384-91.
57. Newton CR, Hearn MT, Yuzpe AA. Psychological assessment and follow-up after in vitro fertilization: assessing the impact of failure. Fertil Steril. 1990; 54(5):879-86.
58. Conklin J. Giving the greatest gift of all: infertile couples fi nd hope in UW's egg donor program. The Online Daily of the University of Washington. 1996.
59. Fielding D, Handley S, Duqueno L, Weaver S, Lui S. Motivation, attitudes and experience of donation: a follow-up of women donating eggs in assisted conception treatment. J Community Appl Soc Psychol. 1998;8(4):273-87.
60. Randal AE. The personal, interpersonal, and political issues of egg donation. J Obstet Gynaecol Can. 2004;26(12):1087-90.
61. Yee S, Hitkari JA, Greenblatt EM. A follow-up study of women who donated oocytes to known recipient couples for altruistic reasons. Hum Reprod. 2007;22(7):2040-50.
62. Safeguards for donors. Nature. 2006;442:601.
63. Schenker JG, Ezra Y. Complications of assisted reproductive techniques. Fertil Steril. 1994;61(3): 411-22.
64. Smitz J, Camus M, Devroey P, Erard P, Wisanto A, Van Steirteghem AC. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Hum Reprod. 1990;5(8):933-7.
65. MacDougall MJ, Tan SL, Jacobs HS. In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod. 1992;7(5):597-600.
66. Delvigne A, Dubois M, Battheu B, et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. II. Multiple discriminant analysis for risk prediction. Hum Reprod. 1993;8(9): 1361-6.
67. Schenker JG. Prevention and treatment of ovarian hyperstimulation. Hum Reprod. 1993;8(5):653-9.
68. Ellison B, Meliker J. Assessing the risk of ovarian hyperstimulation syndrome in egg donation: implications for human embryonic stem cell research. Am J Bioeth. 2011;11(9):22-30.
69. Budev MM, Arroliga AC, Falcone T. Ovarian hyperstimulation syndrome. Crit Care Med. 2005;33(10 Suppl):S301-6.
70. Donor conception factsheet. Infertility network 2009. http://www.infertilitynetwork.org/ files/FactSheet-DC.pdf Accessed 10 Aug 2011.
71. Klemetti R, Sevon T, Gissler M, Hemminki E. Complications of IVF and ovulation induction. Hum Reprod. 2005;20(12):3293-300.
72. Kaye M. Who should pay for IVF? UofT Magazine. 2010. http://www.magazine.utoronto.ca/summer-2010/ ivf-treatment-cost-canada-ted-brown/ .
73. Macinko JA, Starfield B. Annotated bibliography on equity in health, 1980-2001. Int J Equity Health. 2002;1(1):1.
74. International Society for Equity and Health. ISEQH 2011; Available at: URL: http://www.iseqh.org/ Accessed 28 July 2011.
75. Starfield B. The hidden inequity in health care. Int J Equity Health. 2011;10:15.
76. Sexton MB, Byrd MR, O'Donohue WT, Jacobs NN. Web-based treatment for infertility-related psychological distress. Arch Womens Ment Health. 2010;13(4):347-58.
77. Domar AD, Smith K, Conboy L, Iannone M, Alper M. A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment. Fertil Steril. 2010;94(4): 1457-9.
78. Canada Health Act (R.S.C., 1985, c. C-6). Department of Justice Canada. http://laws-lois.justice.gc.ca/eng/ acts/C-6/ Accessed 11 Aug 2011.
79. Canadian Charter of Rights and Freedoms. Department of Justice Canada 1982. http://laws.justice.gc.ca/en/ Charter/index.html Accessed 11 Oct 2011.
80. The Expert Panel on Infertility and Adoption. Raising expectations: recommendations of the expert panel on infertility and adoption. Ministry of Children and Youth Services 2009. http://www.children.gov.on.ca/htdocs/ English/infertility/index.aspx Accessed 30 Sept 2011.
81. Nisker J. Response to Quebec challenge to the assisted human reproduction act. Prepared for the Justice Department. 2006.
82. Nisker JA. In quest of the perfect analogy for using in vitro fertilization patients as oocyte donors. Womens Health Issues. 1997;7(4):241-7.
83. Nisker JA. Physician obligation in oocyte procurement. Am J Bioeth. 2001;1(4):22-3.
84. Blackwell T. The impotency of Canada's fertility laws. Centre for Genetics and Society 2009. http:// www.geneticsandsociety.org/article.phpid=4534 Accessed 15 Aug 2011.
85. Gurmankin AD. Risk information provided to prospective oocyte donors in a preliminary phone call. Am J Bioeth. 2001;1(4):3-13.
86. Spar D. The egg trade -making sense of the market for human oocytes. N Engl J Med. 2007;356(13): 1289-91.
87. Beeson D, Lippman A. Egg harvesting for stem cell research: medical risks and ethical problems. Reprod Biomed Online. 2006;13(4):573-9.
88. Bell AV. Beyond ( fi nancial) accessibility: inequalities within the medicalisation of infertility. Sociol Health Illn. 2010;32(4):631-46.
89. Shen fi eld F, Steele SJ. A gift is a gift is a gift, or why gamete donors should not be paid. Hum Reprod. 1995;10(2):253-5.
90. Echo. The Ontario women's health framework. Echo 2011. http://www.echo-ontario.ca/sites/default/files/ Women%27s%20Health%20Framework-FINALENG-Web-jp2%5B1%5D-0.pdf Accessed 6 Sept 2011.
91. Bierman AS, Ahmad F, Angus J, et al. Burden of illness. In: Bierman AS, editor. Project for an Ontario women's health evidence-based report: Volume 1: Toronto; 2009. http://www.powerstudy.ca/webfm-send/41.
92. Bleyer WA. The impact of childhood cancer on the United States and the world. CA Cancer J Clin. 1990;40(6):355-67.
93. Gatta G, Capocaccia R, Coleman MP, Ries LA, Berrino F. Childhood cancer survival in Europe and the United States. Cancer. 2002;95(8):1767-72.
94. Bleyer WA. What can be learned about childhood cancer from "cancer statistics review 1973-1988". Cancer. 1993;71(10 Suppl):3229-36.
95. Rao GD, Tan SL. In vitro maturation of oocytes. Semin Reprod Med. 2005;23(3):242-7.
96. Poirot C, Vacher-Lavenu MC, Helardot P, Guibert J, Brugieres L, Jouannet P. Human ovarian tissue cryopreservation: indications and feasibility. Hum Reprod. 2002;17(6):1447-52.
97. Rosoff PM, Katsur ML. Preserving fertility in young cancer patients: a medical, ethical and legal challenge. J Philos Sci Law. 2003;3. http://www6.miami.edu/ ethics/jpsl/archives/papers/preservingFert.html.
98. Snyder KA, Pearse W. Discussing fertility preservation options with patients with cancer. JAMA. 2011;306(2):202-3.
99. Quinn GP, Vadaparampil ST, Gwede CK, et al. Discussion of fertility preservation with newly diagnosed patients: oncologists' views. J Cancer Surviv. 2007;1(2):146-55.
100. Blumenfeld Z. Gynaecologic concerns for young women exposed to gonadotoxic chemotherapy. Curr Opin Obstet Gynecol. 2003;15(5):359-70.
101. Blyth E, Frith L. Donor-conceived people's access to genetic and biographical history: an analysis of provisions in different jurisdictions permitting disclosure of donor identity. Int J Law, Policy Fam. 2009;23:174-91.
102. Moyal D, Shelley C. Future child's rights in new reproductive technology: thinking outside the tube and maintaining the connections. Fam Court Rev. 2010;48(3):431-46.
103. Cameron A, Gruben V, Kelly F. De-Anonymising Sperm Donors in Canada: Some doubts and directions. Canadian Journal of Family Law. 2010;26:95-148.
104. Frith L. Telling is more important than ever: rights and donor conception. BioNews 2010. http://www. bionews.org.uk/page-53094.asp Accessed 6 Sept 2011.
105. Baylis F. The forgotten rights of donor offspring. The Mark 2010. http://www.themarknews.com/ articles/2652-the-forgotten-rights-of-donor-offspring Accessed 6 Sept 2011.
106. Lloyd EC, Barth RP. Developmental outcomes after fi ve years for foster children returned home, remaining in care, or adopted. Child Youth Serv Rev. 2011;33(8):1383-91.
107. Hughes EG, Beecroft ML, Wilkie V, et al. A multicentre randomized controlled trial of expectant management versus IVF in women with fallopian tube patency. Hum Reprod. 2004;19(5):1105-9.
108. Noonan J. Between egoism and altruism: outlines for a materialist conception of the good. Crit Rev Int Soc Pol Philos. 2002;5:68-86.
109. Frank AW. The renewal of generosity: illness, medicine, and how to live. Chicago: The University of Chicago Press; 2004.
110. Nisker J, White A. The CMA code of ethics and the donation of fresh embryos for stem cell research. CMAJ. 2005;173(6):621-2.
111. Fehr E, Fischbacher U. The nature of human altruism. Nature. 2003;425(6960):785-91.
112. Dawkins R. The sel fi sh gene: 30th anniversary edition. London: Oxford University Press; 2006.
113. Gorrill MJ, Johnson LK, Patton PE, Burry KA. Oocyte donor screening: the selection process and cost analysis. Fertil Steril. 2001;75(2):400-4.
114. Murray C, Golombok S. Oocyte and semen donation: a survey of UK licensed centres. Hum Reprod. 2000;15(10):2133-9.
115. United Kingdom. Regulation of research on human embryos. Human fertilisation and embryology authority. 1990. http://www.legislation.gov.uk/ ukpga/1990/37/contents.
116. Marina S, Exposito R, Marina F, Nadal J, Masramon M, Verges A. Oocyte donor selection from 554 candidates. Hum Reprod. 1999;14(11):2770-6.
117. Soderstrom-Anttila V. Follow-up study of Finnish volunteer oocyte donors concerning their attitudes to oocyte donation. Hum Reprod. 1995;10(11): 3073-6.
118. Kan AK, Abdalla HI, Ogunyemi BO, Korea L, Latarche E. A survey of anonymous oocyte donors: demographics. Hum Reprod. 1998;13(10):2762-6.
119. Lornage J, Chorier H, Boulieu D, Mathieu C, Czyba JC. Six year follow-up of cryopreserved human embryos. Hum Reprod. 1995;10(10):2610-6.
120. Van Voorhis BJ, Grinstead DM, Sparks AE, Gerard JL, Weir RF. Establishment of a successful donor embryo program: medical, ethical, and policy issues. Fertil Steril. 1999;71(4):604-8.
121. Soderstrom-Anttila V, Foudila T, Ripatti UR, Siegberg R. Embryo donation: outcome and attitudes among embryo donors and recipients. Hum Reprod. 2001;16(6):1120-8.
122. Newton CR, McDermid A, Tekpetey F, Tummon IS. Embryo donation: attitudes toward donation procedures and factors predicting willingness to donate. Hum Reprod. 2003;18(4):878-84.
123. Saunders DM, Garner F. Oocyte donation using "known" donors: it may seem the convenient answer but who pays? Hum Reprod. 1996;11(11):2356-7.
124. Nisker J, White A, Tekpetey F, Feyles V. Development and investigation of a free and informed choice process for embryo donation to stem cell research in Canada. J Obstet Gynaecol Can. 2006;28(10): 903-8.
125. Sherwin S. No longer patient: feminist ethics and health care. Philadelphia: Temple University Press; 1992.
126. Ginsburg F, Rapp R. The difference that disability makes: Reproductive justice through a wider lens. In: Jordan-Young R, editor. Critical conceptions: technology, justice, and the global reproductive market. Scholar & Feminist Online. Fall 2010/Spring 2011;9.1-9.2. http://sfonline.barnard.edu/reprotech/